David Kaslow
Director, CBER Office of Vaccines Research and Review
Estimated Net Worth
- $1.9 M - $5.3 M
Salary
- Unknown
Employment
- Started 10/09/2022
Records
[#]
Indicates number of lines involving "World Health Organization".
Financial Disclosure Details - OGE Form 278e (11/10/2022)
Positions Held Outside United States Government
# | Organization | City | Position | To |
|---|---|---|---|---|
5 | Geneva, Outside U.S. | Chair, IVR/WHO Product Development for Vaccine Advisory Committee | 10/2022 | |
6 | Geneva, Outside U.S. | Ex officio member, WHO SAGE Working Group on COVID-19 Vaccines | 10/2022 | |
7 | Geneva, Outside U.S. | Lead, Strategic Priority 7 (Research and Innovation) Working Group | 10/2022 | |
17 | Geneva, Outside U.S. | Co-Chair, Advisory Group on therapeutic HPV vaccines | 10/2022 |
Do you have information about David Kaslow that is missing from this database?
Drop us a line at [email protected].